GNL Gut and Liver
  1. Jun Kato, Takeichi Yoshida, Sakiko Hiraoka. Prediction of treatment outcome and relapse in inflammatory bowel disease. Expert Review of Clinical Immunology 2019;15:667
    https://doi.org/10.1080/1744666X.2019.1593140
  2. Dae Gon Ryu, Hyung Wook Kim, Su Bum Park, Dae Hwan Kang, Cheol Woong Choi, Su Jin Kim, Hyeong Seok Nam. Clinical implications of fecal calprotectin and fecal immunochemical test on mucosal status in patients with ulcerative colitis. 2019;98:e17080
    https://doi.org/10.1097/MD.0000000000017080
  3. Antonia MD Churchhouse, Victoria EL Moffat, Christian P Selinger, Christopher A Lamb, Michelle J Thornton, Ian Penman, Shahida Din. British Society of Gastroenterology interim framework for addressing the COVID-19-related backlog in inflammatory bowel disease colorectal cancer surveillance. Gut 2023;72:1631
    https://doi.org/10.1136/gutjnl-2022-328309
  4. Sakiko Hiraoka, Shiho Takashima, Toshihiro Inokuchi, Asuka Nakarai, Masahiro Takahara, Keita Harada, Yasuhiro Seki, Katsunori Watanabe, Jun Kato, Hiroyuki Okada. The novel latex agglutination turbidimetric immunoassay system for simultaneous measurements of calprotectin and hemoglobin in feces. Intest Res 2019;17:202
    https://doi.org/10.5217/ir.2018.00086
  5. Monica State, Lucian Negreanu, Theodor Voiosu, Andrei Voiosu, Paul Balanescu, Radu Bogdan Mateescu. Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review. WJG 2021;27:1828
    https://doi.org/10.3748/wjg.v27.i16.1828
  6. Natsuki Ishida, Tomohiro Higuchi, Takahiro Miyazu, Satoshi Tamura, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto. C-reactive protein is superior to fecal biomarkers for evaluating colon-wide active inflammation in ulcerative colitis. Sci Rep 2021;11
    https://doi.org/10.1038/s41598-021-90558-z
  7. Mindy Winghin Lee, Jonathan S. Pourmorady, Loren Laine. Use of Fecal Occult Blood Testing as a Diagnostic Tool for Clinical Indications: A Systematic Review and Meta-Analysis. Am J Gastroenterol 2020;115:662
    https://doi.org/10.14309/ajg.0000000000000495
  8. Satohiro Matsumoto, Hirosato Mashima. Usefulness of the Optimal Cutoff Value and Delta Value of Leucine-Rich Alpha 2 Glycoprotein in Ulcerative Colitis. 2022;4
    https://doi.org/10.1093/crocol/otac039
  9. Natsuki Ishida, Satoshi Tamura, Takahiro Miyazu, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto. Comparison between Prostaglandin E-major urinary metabolite and C-reactive protein levels to reflect endoscopic scores in patients with ulcerative colitis. Sci Rep 2021;11
    https://doi.org/10.1038/s41598-021-95761-6
  10. Joana Torres, Jonas Halfvarson, Iago Rodríguez-Lago, Charlotte R H Hedin, Tine Jess, Marla Dubinsky, Kenneth Croitoru, Jean-Frédéric Colombel. Results of the Seventh Scientific Workshop of ECCO: Precision Medicine in IBD—Prediction and Prevention of Inflammatory Bowel Disease. 2021;15:1443
    https://doi.org/10.1093/ecco-jcc/jjab048
  11. Changchang Ge, Yi Lu, Hong Shen, Lei Zhu. Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis. Scandinavian Journal of Gastroenterology 2022;57:513
    https://doi.org/10.1080/00365521.2021.2022193
  12. Eriko Yasutomi, Sakiko Hiraoka, Shumpei Yamamoto, Shohei Oka, Mami Hirai, Yasushi Yamasaki, Toshihiro Inokuchi, Hideaki Kinugasa, Masahiro Takahara, Keita Harada, Jun Kato, Hiroyuki Okada. Switching between Three Types of Mesalazine Formulation and Sulfasalazine in Patients with Active Ulcerative Colitis Who Have Already Received High-Dose Treatment with These Agents. JCM 2019;8:2109
    https://doi.org/10.3390/jcm8122109
  13. Ji Young Chang, Jae Hee Cheon. Fecal Immunochemical Test and Fecal Calprotectin Measurement Are Noninvasive Monitoring Tools for Predicting Endoscopic Activity in Patients with Ulcerative Colitis. Gut and Liver 2018;12:117
    https://doi.org/10.5009/gnl17445
  14. Jennifer Murray, Klaartje B Kok, Ruth M Ayling. Fecal Calprotectin in Gastrointestinal Disease. 2023;69:699
    https://doi.org/10.1093/clinchem/hvad051
  15. Eriko Yasutomi, Toshihiro Inokuchi, Sakiko Hiraoka, Kensuke Takei, Shoko Igawa, Shumpei Yamamoto, Masayasu Ohmori, Shohei Oka, Yasushi Yamasaki, Hideaki Kinugasa, Masahiro Takahara, Keita Harada, Masaki Furukawa, Kouichi Itoshima, Ken Okada, Fumio Otsuka, Takehiro Tanaka, Toshiharu Mitsuhashi, Jun Kato, Hiroyuki Okada. Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease. Sci Rep 2021;11
    https://doi.org/10.1038/s41598-021-90441-x
  16. Jared Matson, Sonia Ramamoorthy, Nicole E. Lopez. The Role of Biomarkers in Surgery for Ulcerative Colitis: A Review. JCM 2021;10:3362
    https://doi.org/10.3390/jcm10153362
  17. Anuj Bohra, Nicholas Batt, Krishneel Dutt, Diana Lewis, Jonathan P. Segal, Olga Newiadomski, Abhinav Vasudevan, Daniel R. Van Langenberg. The synergy of dual faecal immunochemical and faecal calprotectin testing for accurate assessment of endoscopic and histological activity in inflammatory bowel disease. Therap Adv Gastroenterol 2024;17
    https://doi.org/10.1177/17562848241237895
  18. Hirotaka Shimizu, Ryo Ebana, Takahiro Kudo, Takuro Sato, Tomoko Hara, Kenji Hosoi, Masaaki Usami, Masashi Yoshida, Ichiro Takeuchi, Hiroshi Nakase, Itaru Iwama, Katsuhiro Arai, Toshiaki Shimizu. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease. J Gastroenterol 2022;57:344
    https://doi.org/10.1007/s00535-022-01856-w
  19. Natsuki Ishida, Kiichi Sugiura, Takahiro Miyazu, Satoshi Tamura, Satoshi Suzuki, Shinya Tani, Mihoko Yamade, Moriya Iwaizumi, Yasushi Hamaya, Satoshi Osawa, Takahisa Furuta, Ken Sugimoto. Prostaglandin E-Major Urinary Metabolite Predicts Relapse in Patients With Ulcerative Colitis in Clinical Remission. Clin Transl Gastroenterol 2020;11:e00289
    https://doi.org/10.14309/ctg.0000000000000289
  20. Kohei Wagatsuma, Yoshihiro Yokoyama, Hiroshi Nakase. Role of Biomarkers in the Diagnosis and Treatment of Inflammatory Bowel Disease. Life 2021;11:1375
    https://doi.org/10.3390/life11121375
  21. Simon P. Borg-Bartolo, Ray Kiran Boyapati, Jack Satsangi, Rahul Kalla. Precision medicine in inflammatory bowel disease: concept, progress and challenges. F1000Res 2020;9:54
    https://doi.org/10.12688/f1000research.20928.1
  22. Kirn Sandhu, Sandhia Naik, Ruth M Ayling. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children. Ann Clin Biochem 2021;58:230
    https://doi.org/10.1177/0004563221989359
  23. Bing-Jie Xiang, Min Jiang, Ming-Jun Sun, Cong Dai. Optimal Range of Fecal Calprotectin for Predicting Mucosal Healing in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Visc Med 2021;37:338
    https://doi.org/10.1159/000514196
  24. Akihiko Oka, Kousaku Kawashima, Kenichi Kishimoto, Satoshi Kotani, Mai Fukunaga, Nobuhiko Fukuba, Yoshiyuki Mishima, Naoki Oshima, Norihisa Ishimura, Muyiwa Awoniyi, Shunji Ishihara. Validation of rapid fecal calprotectin assay using particle enhanced turbidimetric immunoassay for inflammatory bowel disease. Sci Rep 2024;14
    https://doi.org/10.1038/s41598-024-51580-z
© 2023. Gut and Liver. / Powered by INFOrang Co., Ltd